Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Erythema, Nausea, Paraesthesia
Clinical narrative: Hurt little to touch; Itchiness at injection site; Parachute looking rash near injection site; Arm felt like prinkly feeling like needle; Light-headedness; Nausea; Redness; Arm pain near injection site; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Arm felt like prinkly feeling like needle), DIZZINESS (Light-headedness), ERYTHEMA (Redness), VACCINATION SITE WARMTH (Hurt little to touch) and VACCINATION SITE PRURITUS (Itchiness at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L2019) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Shingrix (Shingrix : As a child fevers) in 2018. Past adverse reactions to the above products included Flu like symptoms with Shingrix. Concurrent medical conditions included Meniere's disease since May 2000. Concomitant products included GLICLAZIDE (DIAZIDE [GLICLAZIDE]) and ALPRAZOLAM (XANAX) for Meniere's disease, WARFARIN SODIUM (JANTOVEN) for Pulmonary embolus.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (Redness) and VACCINATION SITE PAIN (Arm pain near injection site). On 25-Jan-2021, the patient experienced PARAESTHESIA (Arm felt like prinkly feeling like needle), DIZZINESS (Light-headedness), VACCINATION SITE WARMTH (Hurt little to touch), VACCINATION SITE PRURITUS (Itchiness at injection site), VACCINATION SITE RASH (Parachute looking rash near injection site) and NAUSEA (Nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 23-Jan-2020 to 30-Jan-2021 at a dose of 1 dosage form once a day; LORATADINE at a dose of 1 dosage form; CLOBETASOL PROPIONATE at a dose of 1 dosage form 0.05%; HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) from 23-Jan-2020 to 28-Jan-2021 at a dose of 1 dosage form twice a day and Manual therapy (Ice pack) for Vaccination site pain. On 25-Jan-2021, DIZZINESS (Light-headedness) and NAUSEA (Nausea) had resolved. On 28-Jan-2021, ERYTHEMA (Redness) and VACCINATION SITE PAIN (Arm pain near injection site) had resolved. On 29-Jan-2021, VACCINATION SITE WARMTH (Hurt little to touch), VACCINATION SITE PRURITUS (Itchiness at injection site) and VACCINATION SITE RASH (Parachute looking rash near injection site) had resolved. At the time of the report, PARAESTHESIA (Arm felt like prinkly feeling like needle) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient got the second vaccination in the opposite arm and did not have a rash this time.  She experienced the more usual side effect for 1.5 days including sore arm, general fatigue.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: VAERS follow-up form is attached: Second dose information , Concomitants, Treatment medications, Allergy, Ethnic group and race are updated. On 29-Jun-2021: Follow-up information received on 29-JUN-2021 contains updated patient ethnic history.